Midway through a M.D./Ph.D program at UCLA, Alice Zhang made a discovery that she felt could reverberate far beyond the halls of academia. So she shifted directions, leaving her Ph.D program to found Verge Genomics, a biomedical firm that aims to unite genetic research and artificial intelligence in service of drug discovery. She describes how AI can revolutionize the drug discovery process, and reframes risk-taking as a simple series of optimistic next steps.
Podden och tillhörande omslagsbild på den här sidan tillhör Stanford eCorner. Innehållet i podden är skapat av Stanford eCorner och inte av, eller tillsammans med, Poddtoppen.
